• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

形成对因暴露于湿气而导致的重结晶具有抗性的无定形固体分散体N-丁基-N-甲基-1-苯基吡咯并[1,2-a]吡嗪-3-甲酰胺的长期物理稳定性。

Creation of Long-Term Physical Stability of Amorphous Solid Dispersions N-Butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide, Resistant to Recrystallization Caused by Exposure to Moisture.

作者信息

Markeev Vladimir B, Blynskaya Evgenia V, Alekseev Konstantin V, Dorofeev Vladimir L, Marakhova Anna I, Vetcher Alexandre A

机构信息

Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, 8 Baltiyskaya Str., 125315 Moscow, Russia.

Institute of Pharmacy and Biotechnology, Peoples' Friendship University of Russia n.a. P. Lumumba (RUDN), 6 Miklukho-Maklaya Str., 117198 Moscow, Russia.

出版信息

Materials (Basel). 2025 Jan 6;18(1):203. doi: 10.3390/ma18010203.

DOI:10.3390/ma18010203
PMID:39795848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11722151/
Abstract

Amorphous solid dispersion (ASD) technology is often used as a promising strategy to improve the solubility of active pharmaceutical ingredients (APIs). ASDs allow APIs to be dispersed at the molecular level in a polymer carrier, destroying the crystalline structure of the APIs and, thanks to the polymer, providing long-term supersaturation in solution. However, stability issues are an obstacle to the development of new medications with ASD. In addition to the molecular mobility at elevated temperatures leading to the crystallization of APIs, moisture affects the physical stability of ASD, leading to fractional separation and recrystallization. N-butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide (GML-3) is an original API with both anxiolytic and antidepressant activity, but its insolubility in water can negatively affect (influence) bioavailability. Our study aims to create ASD GML-3 with moisture-resistant polymers (Soluplus, HPC) and assess the stability of the amorphous state of ASD after storage in high humidity conditions. As a result, HPC Klucel FX was revealed to be more stable than the brand, providing a high level of API release into the purified water environment and stability after 21 days (3 weeks) of storage in high humidity conditions.

摘要

无定形固体分散体(ASD)技术常被用作一种有前景的策略来提高活性药物成分(API)的溶解度。ASD能使API在聚合物载体中以分子水平分散,破坏API的晶体结构,并且借助聚合物在溶液中提供长期过饱和状态。然而,稳定性问题是ASD新型药物开发的一个障碍。除了高温下的分子运动导致API结晶外,水分也会影响ASD的物理稳定性,导致分层分离和重结晶。N-丁基-N-甲基-1-苯基吡咯并[1,2-a]吡嗪-3-甲酰胺(GML-3)是一种具有抗焦虑和抗抑郁活性的原创API,但其在水中的不溶性会对生物利用度产生负面影响。我们的研究旨在用防潮聚合物(固体分散体、羟丙基纤维素)制备GML-3的ASD,并评估在高湿度条件下储存后ASD无定形状态的稳定性。结果表明,羟丙基纤维素Klucel FX比该品牌更稳定,在高湿度条件下储存21天(3周)后,能在纯化水环境中实现高水平的API释放并保持稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/9148ebb0bc80/materials-18-00203-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/7367539b7416/materials-18-00203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/0c0df5d0d45f/materials-18-00203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/98016af98997/materials-18-00203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/d8b6d6543219/materials-18-00203-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/4084e4726a9a/materials-18-00203-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/6d6d7c2630c7/materials-18-00203-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/89cd3ca9eba7/materials-18-00203-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/9148ebb0bc80/materials-18-00203-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/7367539b7416/materials-18-00203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/0c0df5d0d45f/materials-18-00203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/98016af98997/materials-18-00203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/d8b6d6543219/materials-18-00203-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/4084e4726a9a/materials-18-00203-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/6d6d7c2630c7/materials-18-00203-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/89cd3ca9eba7/materials-18-00203-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00f2/11722151/9148ebb0bc80/materials-18-00203-g008.jpg

相似文献

1
Creation of Long-Term Physical Stability of Amorphous Solid Dispersions N-Butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide, Resistant to Recrystallization Caused by Exposure to Moisture.形成对因暴露于湿气而导致的重结晶具有抗性的无定形固体分散体N-丁基-N-甲基-1-苯基吡咯并[1,2-a]吡嗪-3-甲酰胺的长期物理稳定性。
Materials (Basel). 2025 Jan 6;18(1):203. doi: 10.3390/ma18010203.
2
Composites of N-butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide with Polymers: Effect of Crystallinity on Solubility and Stability.N-正丁基-N-甲基-1-苯基吡咯并[1,2-a]吡嗪-3-甲酰胺与聚合物的复合材料:结晶度对溶解度和稳定性的影响。
Int J Mol Sci. 2023 Jul 30;24(15):12215. doi: 10.3390/ijms241512215.
3
A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions.用于预测无定形固体分散体物理稳定性的机械模型。
J Pharm Sci. 2021 Apr;110(4):1495-1512. doi: 10.1016/j.xphs.2020.08.006. Epub 2020 Aug 18.
4
Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.从过饱和喷雾干燥无定形固体分散体中测定药物-聚合物溶解度:以依非韦伦和Soluplus®为例。
Eur J Pharm Biopharm. 2019 Sep;142:300-306. doi: 10.1016/j.ejpb.2019.06.028. Epub 2019 Jun 24.
5
Modeling of the Aqueous Solubility of N-butyl-N-methyl-1-phenylpyrrolo[1,2-a] pyrazine-3-carboxamide: From Micronization to Creation of Amorphous-Crystalline Composites with a Polymer.N-丁基-N-甲基-1-苯基吡咯并[1,2-a]吡嗪-3-甲酰胺的水溶解度建模:从微粉化到与聚合物形成非晶-结晶复合材料
Polymers (Basel). 2023 Oct 18;15(20):4136. doi: 10.3390/polym15204136.
6
Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?将晶型和聚合型辅料组合在原料药固体分散体中-机遇还是风险?
Eur J Pharm Biopharm. 2021 Jan;158:323-335. doi: 10.1016/j.ejpb.2020.11.025. Epub 2020 Dec 6.
7
Amorphous Solid Dispersions of Glycyrrhetinic Acid: Using Soluplus, PVP, and PVPVA as the Polymer Matrix to Enhance Solubility, Bioavailability, and Stability.甘草次酸的无定形固体分散体:使用聚乙烯己内酰胺-聚乙酸乙烯酯-聚乙二醇接枝共聚物(Soluplus)、聚乙烯吡咯烷酮(PVP)和聚乙烯吡咯烷酮-醋酸乙烯酯共聚物(PVPVA)作为聚合物基质来提高溶解度、生物利用度和稳定性。
AAPS PharmSciTech. 2024 Dec 21;26(1):18. doi: 10.1208/s12249-024-03007-1.
8
Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.聚乙烯吡咯烷酮和聚乙烯吡咯烷酮-醋酸乙烯酯无定形固体分散体的长期物理稳定性
Mol Pharm. 2017 Jan 3;14(1):157-171. doi: 10.1021/acs.molpharmaceut.6b00763. Epub 2016 Dec 7.
9
Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.无定形固体分散体的水分诱导无定形相分离:分子机制、微观结构及其对溶解性能的影响。
J Pharm Sci. 2018 Jan;107(1):317-326. doi: 10.1016/j.xphs.2017.10.028. Epub 2017 Oct 26.
10
Synergistic and antagonistic effects of various amphiphilic polymer combinations in enhancing griseofulvin release from ternary amorphous solid dispersions.各种两亲性聚合物组合在增强三元无定形固体分散体中灰黄霉素释放方面的协同和拮抗作用。
Eur J Pharm Sci. 2020 Jul 1;150:105354. doi: 10.1016/j.ejps.2020.105354. Epub 2020 May 4.

本文引用的文献

1
Mechanisms of dissolution and crystallization of amorphous glibenclamide.无定形格列本脲的溶解和结晶机制。
Int J Pharm. 2024 Dec 5;666:124820. doi: 10.1016/j.ijpharm.2024.124820. Epub 2024 Oct 16.
2
6-Carboxycellulose Acetate Butyrate: Effectiveness as an Amorphous Solid Dispersion Polymer.醋酸丁酸纤维素:作为无定形固体分散聚合物的有效性。
Mol Pharm. 2024 Sep 2;21(9):4589-4602. doi: 10.1021/acs.molpharmaceut.4c00493. Epub 2024 Aug 1.
3
Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023.
2012年至2023年间美国食品药品监督管理局批准的无定形固体分散体药物产品的趋势。
Int J Pharm X. 2024 Jun 3;7:100259. doi: 10.1016/j.ijpx.2024.100259. eCollection 2024 Jun.
4
Self-nanomicellizing solid dispersion: A promising platform for oral drug delivery.自纳米胶束化固体分散体:口服药物传递的有前途的平台。
Colloids Surf B Biointerfaces. 2024 Sep;241:114057. doi: 10.1016/j.colsurfb.2024.114057. Epub 2024 Jun 24.
5
Accelerated stability modeling of recrystallization from amorphous solid Dispersions: A Griseofulvin/HPMC-AS case study.无定形固体分散体再结晶的加速稳定性建模:灰黄霉素/ HPMC-AS 案例研究。
Int J Pharm. 2024 May 25;657:124189. doi: 10.1016/j.ijpharm.2024.124189. Epub 2024 May 1.
6
Modeling of the Aqueous Solubility of N-butyl-N-methyl-1-phenylpyrrolo[1,2-a] pyrazine-3-carboxamide: From Micronization to Creation of Amorphous-Crystalline Composites with a Polymer.N-丁基-N-甲基-1-苯基吡咯并[1,2-a]吡嗪-3-甲酰胺的水溶解度建模:从微粉化到与聚合物形成非晶-结晶复合材料
Polymers (Basel). 2023 Oct 18;15(20):4136. doi: 10.3390/polym15204136.
7
Strategies to improve the stability of amorphous solid dispersions in view of the hot melt extrusion (HME) method.基于热熔挤出(HME)法提高无定形固体分散体稳定性的策略。
Int J Pharm. 2023 Nov 25;647:123536. doi: 10.1016/j.ijpharm.2023.123536. Epub 2023 Oct 20.
8
Composites of N-butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide with Polymers: Effect of Crystallinity on Solubility and Stability.N-正丁基-N-甲基-1-苯基吡咯并[1,2-a]吡嗪-3-甲酰胺与聚合物的复合材料:结晶度对溶解度和稳定性的影响。
Int J Mol Sci. 2023 Jul 30;24(15):12215. doi: 10.3390/ijms241512215.
9
Polymer-mediated and ultrasound-assisted crystallization of ropivacaine: Crystal growth and morphology modulation.聚合物介导和超声辅助罗哌卡因结晶:晶体生长和形态调节。
Ultrason Sonochem. 2023 Jul;97:106475. doi: 10.1016/j.ultsonch.2023.106475. Epub 2023 Jun 9.
10
Effect of Molecular Weight on the Dissolution Profiles of PEG Solid Dispersions Containing Ketoprofen.分子量对含酮洛芬聚乙二醇固体分散体溶出曲线的影响
Polymers (Basel). 2023 Mar 31;15(7):1758. doi: 10.3390/polym15071758.